BerganKDV Wealth Management’s AstraZeneca AZN Stock Holding History

BerganKDV Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$32.3K	Hold	226	–	–	﹤0.01%	432
2023 Q1	$31.3K	Hold	226	–	–	﹤0.01%	450
2022 Q4	$30.6K	Sell	226 -112	-33%	-$14K	﹤0.01%	443
2022 Q3	$37K	Sell	338 -75	-18%	-$9.52K	﹤0.01%	403
2022 Q2	$55K	Sell	413 -8	-2%	-$1.05K	0.01%	367
2022 Q1	$56K	Hold	421	–	–	0.01%	388
2021 Q4	$49K	Hold	421	–	–	0.01%	423
2021 Q3	$51K	Buy	421 +90	+27%	+$10.5K	0.01%	396
2021 Q2	$40K	Hold	331	–	–	﹤0.01%	422
2021 Q1	$33K	Hold	331	–	–	﹤0.01%	420
2020 Q4	$33K	Buy	331 +44	+15%	+$4.66K	﹤0.01%	401
2020 Q3	$31K	Buy	287 +30	+12%	+$3.34K	﹤0.01%	380
2020 Q2	$27K	Buy	257 +51	+25%	+$5.27K	﹤0.01%	420
2020 Q1	$18K	Buy	206 +32	+18%	+$3.01K	﹤0.01%	428
2019 Q4	$17K	Buy	174 +120	+222%	+$11.3K	﹤0.01%	467
2019 Q3	$5K	Hold	54	–	–	﹤0.01%	551
2019 Q2	$4K	Hold	54	–	–	﹤0.01%	597
2019 Q1	$4K	Hold	54	–	–	﹤0.01%	600
2018 Q4	$4K	Buy	+54	New	+$4.22K	﹤0.01%	554

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BerganKDV Wealth Management's AZN Position: Q2 2023 in Review

BerganKDV Wealth Management held its AstraZeneca (AZN) position steady in Q2 2023 at 226 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #432.

BerganKDV Wealth Management first reported a position in AZN in Q4 2018 and has held it in 19 quarters since. The position peaked at $56K in Q1 2022. 1,090 funds tracked by Wall St. Rank hold AZN as of Q2 2023.

BerganKDV Wealth Management held 226 shares of AstraZeneca worth $32.3K as of Q2 2023.
BerganKDV Wealth Management left its AstraZeneca share count unchanged in Q2 2023.
AstraZeneca made up ﹤0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #432 holding.
BerganKDV Wealth Management first reported a position in AstraZeneca in Q4 2018 and has held it in 19 quarters since.
BerganKDV Wealth Management's AstraZeneca position peaked at $56K in Q1 2022.
1,090 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.